Dabigatran etexilate

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Atrial fibrillation prevention of stroke and systemic embolism

Manufacturer:

Boehringer Ingelheim

Call for patient/clinician input open:

October 29, 2010

Brand Name:

Pradaxa

Project Line:

Reimbursement Review

Project Number:

SR0214-000

Call for patient/clinician input closed:

November 18, 2010

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Atrial fibrillation prevention of stroke and systemic embolism

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

June 22, 2011

Last Updated : October 28, 2010